To further characterize the deubiquitination substrates of MDM2, we employed an affinity-based ubiquitinated peptide enrichment approach to systematically quantify the change of ubiquitinome in the eWAT of Mdm2-AKI and control mice on HFD for 12 weeks. This evidence concerns the gene MDM2 and acute kidney injury.